# Selective JAK1 Inhibitors for the Treatment of Atopic Dermatitis: Focus on Upadacitinib and Abrocitinib

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/selective-jak1-inhibitors-for-the-treatment-of-atopic-dermatitis-focus-on/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Sandra Ferreira,Emma Guttman‐Yassky,Tiago Torres |
| Citations | 128 |
| DOI | 10.1007/s40257-020-00548-6 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W3048673809 |
| PMID | 32776305 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Tiago Torres](https://scholariq.org/researchers/tiago-torres/)

## Paper primary topic

- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)

## Paper topics

- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)
- [Allergic Rhinitis and Sensitization](https://scholariq.org/topics/allergic-rhinitis-and-sensitization/)
- [IL-33, ST2, and ILC Pathways](https://scholariq.org/topics/il-33-st2-and-ilc-pathways/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.